Former Kolon Chairman Lee Woong-yeol Denies Charges in 'Invossa Suspicion'... "I Only Received Reports"
[Asia Economy Reporter Seongpil Cho] The former chairman of Kolon Group, Lee Woong-yeol, who was indicted over allegations surrounding the osteoarthritis treatment Invossa K, denied all charges.
Lee's defense attorney stated at the preparatory hearing held on the 14th at the Seoul Central District Court Criminal Division 24 (Presiding Judge So Byeong-seok), "The defendant was only informed about important matters concerning the entire group or its affiliates and did not give specific instructions or participate in decision-making." Lee did not appear in court that day.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Wallets Open Wide on Big News...300 Trillion Won Heads to the U.S., "Tax Breaks" Fail to Keep Funds at Home
- "Realizing How Fast Money Disappears: Should You Try Only the Essentials for 5,000 Won? [The Basics of Benefits]"
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
Previously, Lee was indicted without detention on charges of manufacturing and selling Invossa using 'kidney-derived cells,' known to carry tumorigenic risks, contrary to the approval details from the Ministry of Food and Drug Safety, generating sales of 16 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
